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The objective of the present study is to assess the use of medication by pregnant women; classify
them regarding therapy group and its risk category; and identify the cost of these drugs. The sample is formed
by 47 pregnant women, in the 20 to 29 year-old age group, from July 2001 to June 2003, in the city of São
Paulo. A specific instrument was used for data collection in family charts and others from the Sistema de
Informação da Atenção Básica (Primary Care System Information). Average of medications used by pregnant
woman was 3.63. Iron sulfate was the most commonly used, followed by antibiotics (78.7%). Regarding risk
category, 34.1% of medications belonged to category B and 16.5% to category C. In the calculation of total
costs of care, expenses with medication accounted for 11.13%. We have seen the need for assessing further
the criteria for use, especially of medications of category C. The higher costs were related to antimicrobials for
the treatment of infections.
DESCRIPTORS: health care costs; pregnant women; drug cost
USO Y COSTO DE MEDICAMENTOS PARA MUJERES EMBARAZADAS DE BAJO RIESGO
El estudio tuvo como objetivos: identificar la utilización de medicamentos por gestantes; clasificarlos
en cuanto al grupo terapéutico, categoría de riesgo e identificar los costos de esos fármacos. La muestra se
constituyó de 47 gestantes, en el grupo etáreo de 20 a 29 años de edad, en el período de julio de 2001 a junio
de 2003, en el municipio de Sao Paulo. Se utilizó un instrumento para la recolección de datos en historias
clínicas de familias y otros del Sistema de Información de la Atención Básica. El promedio de medicamentos
consumidos fue de 3,63 por gestante. El sulfato ferroso fue el más utilizado, seguido de 78,7% antimicrobianos.
En cuanto a la categoría de riesgo, 34,1% pertenecían a la categoría B, 16,5% a la categoría C. En el análisis
de los costos totales de atención, el gasto de medicamentos representó el 11,13%. Se vislumbró la necesidad
de profundizar en el análisis de los criterios para el uso, especialmente a los de la categoría C. Los costos más
elevados estuvieron relacionados a los antimicrobianos para el tratamiento de infecciones.
DESCRIPTORES: costos de la atención en salud; mujeres embarazadas; costos en drogas
UTILIZAÇÃO E CUSTO DE MEDICAMENTOS EM GESTANTES DE BAIXO-RISCO
O estudo teve como objetivos: verificar a utilização de medicamentos por gestantes; classificá-los
quanto ao grupo terapêutico e sua categoria de risco; identificar os custos desses fármacos. A amostra constituiu-
se de 47 gestantes, na faixa etária de 20 a 29 anos, no período de julho de 2001 a junho de 2003, no município
de São Paulo. Utilizou-se instrumento específico para coleta de dados em prontuários de famílias e outros do
Sistema de Informação da Atenção Básica. A média de medicamentos consumidos foi de 3,63 por gestante. O
sulfato ferroso foi o mais utilizado seguido de antibióticos (78,7%). Quanto à categoria de risco, 34,1% dos
medicamentos pertenciam à categoria B e 16,5% à categoria C. Na apuração de custos totais de atendimento,
o gasto com medicamentos representou 11,13%. Vislumbrou-se a necessidade de aprofundamento da análise
dos critérios para uso, especialmente dos medicamentos da categoria C. Os custos mais elevados estiveram
relacionados aos antimicrobianos para o tratamento de infecções.
DESCRITORES: custos de cuidados de saúde; gestantes; custos de medicamentos
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INTRODUCTION
In Brazil, after Sanitation reform, all health
professions had increased responsibility and
consequently more opportunities to use their
knowledge, including in Nursing. This phenomenon was
associated with changes in paradigms of the health/
disease concept, and the approval of Leis Orgânicas
da Saúde (Organic Health Law # 8.080/90, and # 8.142/
90, with their principles and guidelines that drove the
technical and management decentralization for the
innovation of services to citizens.
There were also significant changes regarding
the adoption of specific policies for the female
population, developing from the Programa Materno
Infantil (Maternal Child Program) to the Programa de
Atenção Integral a Saúde da Mulher (Brazilian
Program of Integral Assistance to Women’s Health
(PAISM), and this marked the development, at the
same time, of the Brazilian National Health System
(SUS). As a model, the first emphasized the biological
view, which is the basis of medical formation that is
still predominant. The phenomenon of “medicalization”
comes from this paradigm(1-3).
PAISM aims at an integral approach of
women’s need in contemporary world, where they
are inserted in the job market, and are using their
civil and political rights that were once only for males.
These events led to new interpretations, especially of
pregnancy which started to include social dimensions
of these women, making and their families with them
as the focus.
Pregnancy is a change that marks lives of
women. It is a set of phenomena that involve women
from conception to the birth of a new human being,
including the change of their role in society. It produces
an unstable biological balance with hormone changes
that occur during the process, leading to behavior,
physiological and biochemical changes. This unique
condition that controls the environment of the fetus is
physiologically controlled by mothers, and it requires
special care concerning the exposure of women to
medications. Therefore, in other clinical specialties
therapeutic risks are not as big as those from
pregnancy, since many of the effects of medications
taken by mothers may lead to significant, irreversible,
morphologic alterations that can occur in different
stages of fetal development(2).
In Brazil, studies show that use of medication
during pregnancy is significant, the percentage of
women using at least one agent during antenatal
ranges from 83.8 to 97.6. Additionally, 33.5% of these
women use over the counter drugs(3-5).
In the Programa de Saúde da Família (Family
Health Program) (PSF), the use of medication by
pregnant women is an important issue since the
standard of attention of physicians and nurses is ruled
by protocols that guide professional actions,
presenting therapeutic indications when necessary,
with standard drugs in antenatal care(6).
The period in pregnancy when drug is used
is an important factor, and can be related to three
stages, the egg from fertilization to implantation; the
embryo from the second to the eight week after
fertilization, and the fetal from the eighth complete
week until the end of pregnancy(2).
The embryo stage corresponds to the classic
teratogenic period, because it encompasses
organogenesis. Before this, drug exposure
determines definitive damage leading either to death
or reabsorption, or to no damage at all, however,
adverse effects may occur in the fetal stage, such as,
for example, with tetracycline. Other factors may
influence placental transfer of drugs, such as level of
absorption, maternal metabolism, protein binding,
electrical charge, molecular weight, and lipid solubility
of the substance(7).
During gestational period, the access of
women to medication is favored by the Programa de
Assistência Farmacêutica (Pharmaceutical Assistance
Program) of SUS. The objective of this program is to
improve integrating economical resources, to increase
financing capacities of services and obtain greater
efficiency in the care of pregnant women(8).
OBJECTIVE
To assess drug use during pregnancy; classify it
according to therapy group and risk and identify costs
of the therapy agents.
METHODOLOGY
Observational, descriptive study on the use
and cost of medication prescribed to pregnant women.
The present study is part from the results of a major
project, assessing the cost of antenatal care in one
unit after PSF introduction.
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The main project was assessed and approved
by the Ethical Research Committee connected with
the Municipal Health Secretariat of the PMSP. We have
also asked for authorization of the board of the Zerbini
Foundation, partner of State Health Secretariat of São
Paulo in the management of this Health Unit (UBS).
The sample was made of 47 pregnant women
performing antenatal control, from July 2001 to June
2003, in a UBS, located in the East side of the city of
São Paulo. Eligibility criteria of this sample included
pregnant women, considered low-risk from 20 to 29
years old, considered lower risk for pregnancy(2).
For data collection, a specific instrument was
designed and tested. This instrument had the identification
of women’s family and follow-up of care during antenatal.
Medications prescribed were extracted at each medical
or nursing appointment, therefore enabling to learn about
the clinical history of the population studied.
Data collection was performed by
researchers, who used family clinical history, record
book of community agents, and the Sistema de
Informação de Atenção Básica (Primary Care System
Information) (SIAB) as information source.
Some social data showed conditions of life of
pregnant women. We have seen that 38.3% (n=18)
of women were in age group from 20 to 22 years old,
29.8% (n=14) from 23 to 25 years old, and 31.9%
(n=15) from 26 to 29 years old. Family profile showed
that 65% of pregnant women lived with 1 to 6
members and 25% had other people living with them
in addition to their family members. These data
indicate a likely reflex of inter-regional migration,
which would partly explain the presence of big families
with other relatives. However, around 10% of the
charts did not present this information.
In outcome processing, medications were
highlighted as a category of direct cost, and were
integrated to one of the spreadsheets of the total costs
of antenatal service. This spreadsheet was part of
the capture of medication prescription for each of the
pregnant women cared for in the period investigated.
To classify medications, we have used the
Alfa System which presents as a main axis, the
therapeutic use of each agent, with later division in
organic and chemical system(7).
Prices of medication were obtained through
the on line Bolsa Eletrônica de Compras (BEC) of the
Government of the State of São Paulo. For some items
specific of odontology, invoices from the researched
Unit have been verified.
We have used US dollar as a reference for
the value of medications so as to make conversion
easier to other countries (average value of dollar in
2003: US$ 2.29).
RESULTS AND DISCUSSION
Currently, basic care uses the policy of
pharmaceutical assistance(8) that incorporates the
principle of integral assistance and access to
medication, with quality on the coverage. It is an
important link in the continuity of care for SUS clients
- most of them have money restrictions.
Table 1 - Distribution of the 47 pregnant women,
according to medication used during pregnancy. Family
Health Unit, Sapopemba. Southeast side of the city of
São Paulo, 2003
noitacideM
nemowtnangerP
N %
etaflusnorI 74 0.001
enorypid+enimalopocS 22 8.64
snimativyloP 41 8.92
elozadinorteM 41 8.92
nixelahpeC 11 4.32
dicaciloF 01 3.12
enimardyhnehpiD 01 3.12
lomatecaraP 9 1.91
nillicipmA 7 9.41
elozanociM 3 4.6
noituloSlasaNenilaS 2 2.4
apodlyhteM 2 2.4
latibrabonehP 2 2.4
enitatsiN 1 1.2
edimarpolcoteM 1 1.2
enorypiD 1 1.2
)enocitemiD(latfuL 1 1.2
)noitacidemyteixna-itna(anijucaraM 1 1.2
Average of medication used by pregnant
women was 3.63, and 25.5% of them were prescribed
9 agents. This result corroborates findings from other
studies that pointed out an average of 4.2 drugs per
pregnant woman(3-5).
Iron sulphate has been prescribed to all
pregnant women (100%), Polyvitamins and folic acid
to 51.1% (Table 1). The subprogram of antenatal care
recommends the use of iron supplement, and the
Nursing Protocol of the SMS(6) establishes that nurses
recommend anti-anemia medication to pregnant
women when clinically justified. Thus, its use is
justified for the whole sample. Although studies show
the efficiency of iron supplement, anemia prevalence
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due to iron deficiency was not reduced, especially in
developing countries(9). WHO stated that 58% of the
pregnant women in these countries are anemic, and
the consequences are preterm labor, children with low
weight, greater morbidity and risk of death during
labor and postpartum period(10).
Polyvitamins (29.8%) and folic acid (21.3%)
were prescribed to a group lower than 30%, although
they are also predicted on the protocol(6). They are
both essential to pregnant women, especially for those
with low income such as those from our sample.
During pregnancy there is an increase in the
need for nutrients, and folic acid, in addition to
decreasing the occurrence of megaloblastic anemia,
decreases the risk of neural-tube malformation(11-12).
A Brazilian study showed that despite the importance
of Polyvitamins and of folic acid, these agents have
been used by 34% and 10% of pregnant women
respectively(13).
Antispasmodic medication and pain killers
(scopolamine, dipyrone and paracetamol) used by
68.1% (n=32) of the sample, have many times been
prescribed with the same purpose, that is, to ease
the pelvic and back pain, that are very frequent in
pregnant women.
Medications of topic use such as
metronidazole and nistatine were used by 15 pregnant
women (31.9%) for the treatment of vaginal
infections. This kind of infection is frequent during
pregnancy however, in the group studied; they may
be associated with conditions of life in addition to the
biological spectrum.
Regarding therapeutic classification,
medications have been organized in such a way that
N indicated the total amount of times it was prescribed
and the respective percentage.
Table 2 - Distribution of medications used during
pregnancy period according to the therapeutic
classification. Family Health Unit, Sapopemba.
Southeast side of the city of São Paulo, 2003
We can see from Table 2 that the therapeutic
class of antiemetics was not commonly indicated
(6.4%), since symptoms such as nausea and vomits
are common in the first trimester. The group of
antibiotics was prescribed to treat urinary infections
in 19 pregnant women (38.3%). Seven of them
presented one episode of infection, four (8.5%) had
repeated infections, and receive antibiotics twice. In
this group of 18, 4 required dental treatment and used
antibiotics to treat dental infections.
Urinary infections are considered one of the
main clinical problems during pregnancy, and
Escherichia coli is the pathogen most commonly
involved. To treat this kind of infection, antimicrobials
are necessary with easy administration, low cost and
no side effects, offering safety for mothers and
fetuses(14). These characteristics are part of ampicillin
and cephalexin, which were prescribed to pregnant
women presenting this clinical condition. Ampicillin was
prescribed in the first trimester, from the 3rd to the
38th week, and only one pregnant woman used
cephalexin in the 12th week.
Table 3 - Distribution of medications used during
pregnancy, according to risk category. Family Health unit,
Sapopemba. Southeast side of the city of São Paulo, 2003
noitacifissalccitueparehT
noitacideM
N %
sgurdcimenaitnA 28 2.84
cidomsapsitnA 42 1.41
scitoibitnA 91 2.11
edicignuF 81 6.01
ciseglanA 21 1.7
scitemeitnA 11 4.6
evisnetrepihitnA 20 2.1
citpelipeitnA 20 2.1
latoT 071 0.001
ksiR
yrogetac
snoitacideM
emancireneG
N %
A 28 2.84 snimativyloP,dicacilof,etaflusnorI
B 85 1.43
,elozadinortem,nixelahpec,nillicipmA
,enimardyhnehpid,lomatecarap
.edimarpolcoteM,elozanocim,enitatsin
C 82 5.61 enimalopocs,enorypid,apodlyhteM
D 2 2.1 latibrabonehP
latoT 071 0.001
Table 3 shows the predominance of
medications from risk category A (48.2%) and B
(34.1%). However, dipyrone, scopolamine and
methyldopa, risk category C were prescribed and in
animal studies, teratogenic effects have been observed
in fetuses but there are no controlled studies in women.
Methyldopa and phenobarbital were recommended for
pregnant women with clinical problems, however, their
use was monitored. Through clinical history, it was seen
that indications occurred due to pictures diagnosed in
phases previous to pregnancy.
The indication for using any medication is a
vital decision, since the essence of treatment was
based on maternal relief and preserving fetal health.
However, surveillance of the effects of these agents
in the reproduction cycle of females is essential.
Use and cost of medication...
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Figure 1 - Representation of the cost of medication per pregnant woman. Family Health Unit, Sapopemba.
Southeast side of the city of São Paulo, 2003
infections, reinforcing the assumption that these situations
required interventions in health education. Thus, we could
reduce costs of medications if the real need for these
medications were better assessed.
Experience obtained in data collection of the
present investigation demonstrated that nurses of the
unit studied were taking up responsibilities of clinical
follow-up of low risk antenatal(15). In the process of
clinical history collection, prescribing was the main
activity, since care records focused on clinical
evolvement rather than the guidelines given to
patients. The other activities of the group in education
actions were not documented as products.
Care protocols that guide technical behavior
regarding prescription of medication are not enough
to assure a risk free practice, because they involve
social dimensions that are beyond prescription.
Pregnant women safety must be monitored through
careful assessment, from social conditions and
examination of physiologic state and pharmacologic
history. In this sense, systematic actions should be
taken to guide health education as mandatory
strategies to develop recommended values in health
promotion and infection prevention.
FINAL CONSIDERATIONS
Results obtained led to the conclusion that drug
prescription to pregnant women is homogeneous, and
the analysis of criteria for it must be further studied,
especially for those women in risk category C.
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Mean cost of medication per pregnant woman
was US$ 26.22 and median US$ 22.08. The group of
pregnant women presenting prescriptions limited to
antianemic drugs and vitamins resulted in US$ 12.20 and
for those requiring interventions the value was US$ 54.65.
Amplitude of this interval occurred because of the 6
pregnant women presenting repeated infections. In a more
detailed analysis, we have seen that without antibiotics,
cost variation of medication in the antenatal period ranged
from US$ 12.20 and US$ 29.96 (Figure 1).
In pregnant women in regular conditions, cost
of medication did not present expressive values.
Antibiotics increased costs. Pregnant women presented
different needs, and specific personnel were allocated
with a division into 3 groups: 37 pregnant women
with no occurrences, 8 requiring dental attention, and
2 were followed-up by the mental health team.
Unusual events were seen in these groups.
Pregnant women in normal, low-risk conditions, the
assumption is that women who used more medications
were those undergoing dental care or being followed-up
by the mental health team. Among the 37 pregnant
women, that had no apparent occurrence, they presented
events that resulted in taking 1 to 9 medications. Those
undergoing dental care (n=8) used 1 to 6 agents and
pregnant receiving mental care took 2 to 5. Among
pregnant women, 12 (32.4%) received therapy for urinary
infection with ampicillin or cephalexin, and among those
receiving dental care, 3 needed antibiotics due to dental
infection, justifying the emergency of this intervention.
The events led to assumptions on the conditions of life of
this population, which would partly explain repeated
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Higher costs were related with the use of
antibiotics, indicated in the treatment of infections
rather than vitamin supplement and others, to
maintain maternal and fetal health.
Currently, the prescription of medication by
nurses, in basic care, is a well known practice that
comes from changes in the role of these professionals
over the years, due to their technical and political
importance in basic care of SUS and from rescuing
their clinical competence, due to the new health
concept. In parallel, the academy needs to go deep
in this issue in the education of these professionals.
If the focus of pregnancy is health, and
medication is used to help pregnant women, then
mothers should be encouraged to take part and be
subjects in this action. These actions will give greater
confidence than the act of prescribing on its own, and
it will also give greater identity to the set of health
care with shared production by users and
professionals. A perspective of production will emerge
from this point of view with social values that go
beyond objective values expressed by currency, such
as health costs.
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